By comparing the low and standard IGF-1 groups, obese subjects with low IGF-1 levels were revealed to be predisposed to increased adiposity, inflammation and metabolic disorders (dyslipidemia and hyperuricemia). This evidence concerns the gene IGF1 and Other metabolic disease.